Ingredion Incorporated
INGRConsumer DefensiveNASDAQPackaged Foods
Scan Results
Daily timeframeIngredion Incorporated, together with its subsidiaries, engages in the manufacture and sale of sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and. At a $6.39B market cap, Ingredion Incorporated ranks as a mid-cap company within consumer defensive. The company operates in Texture & Healthful Solutions; Food & Industrial IngredientsLATAM; and Food & Industrial IngredientsU.S./CANADA segments.
Market Cap
$6.39B
Beta
0.61
P/E (TTM)
11.01
P/E (Fwd)
8.92
EPS (TTM)
$9.20
EPS (Fwd)
$11.35
ROE
13.7%
ROA
7.3%
Cash
$952.0M
Total Debt
$1.78B
Free CF
$457.2M
52W Change
-20.3%
Annual Financials
Cash vs Debt
Where INGR stands vs its 150-day and 200-day moving averages
As of the August 31, 2026 close, INGR finished 1.93% below its 150-day moving average ($106.68) and 2.27% below its 200-day moving average ($107.05). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is INGR overbought or oversold?
At the August 31, 2026 close, INGR's RSI(14) was 54.2, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Ingredion Incorporated carries $1.78B in total debt against $952.0M in cash reserves — debt is roughly 1.9x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $457.2M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 13.7% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $7.95B (2022) to $7.22B (2025).
With a beta below 0.7, Ingredion Incorporated typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing INGR.